ARQ-151 0.3% cream
ARQ-151-302
Phase 3 small_molecule completed
Quick answer
ARQ-151 0.3% cream for Chronic Plaque Psoriasis is a Phase 3 program (small_molecule) at Arcutis Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcutis Biotherapeutics
- Indication
- Chronic Plaque Psoriasis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed